SALIX PHARMACEUTICALS LTD: key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2014)
- $1.1B
- Net Income/Loss (FY2014)
- -$414.9M
- Total Assets (FY2014)
- $4.1B
- Total Equity (FY2014)
- $238.2M
- Cash Flows from Operating Activities (FY2014)
- $4.2M
Source: SALIX PHARMACEUTICALS LTD 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
